{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2025:GLBZL6TAHYUR3U7MXWIAKP6IOU","short_pith_number":"pith:GLBZL6TA","canonical_record":{"source":{"id":"2506.00556","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"stat.ME","submitted_at":"2025-05-31T13:24:05Z","cross_cats_sorted":[],"title_canon_sha256":"cba29baa62b05578d3d808bd2ff1b40458d99bbfa77bdc4b7ac3a2e84b594b66","abstract_canon_sha256":"6b9d77f34aac675a84c098a9cfe57275798e01ce7d7947dd5e312af90385cddb"},"schema_version":"1.0"},"canonical_sha256":"32c395fa603e291dd3ecbd90053fc8751955501391e27efd52ff9cc77a2ff8ba","source":{"kind":"arxiv","id":"2506.00556","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2506.00556","created_at":"2026-07-05T11:13:36Z"},{"alias_kind":"arxiv_version","alias_value":"2506.00556v1","created_at":"2026-07-05T11:13:36Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2506.00556","created_at":"2026-07-05T11:13:36Z"},{"alias_kind":"pith_short_12","alias_value":"GLBZL6TAHYUR","created_at":"2026-07-05T11:13:36Z"},{"alias_kind":"pith_short_16","alias_value":"GLBZL6TAHYUR3U7M","created_at":"2026-07-05T11:13:36Z"},{"alias_kind":"pith_short_8","alias_value":"GLBZL6TA","created_at":"2026-07-05T11:13:36Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2025:GLBZL6TAHYUR3U7MXWIAKP6IOU","target":"record","payload":{"canonical_record":{"source":{"id":"2506.00556","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"stat.ME","submitted_at":"2025-05-31T13:24:05Z","cross_cats_sorted":[],"title_canon_sha256":"cba29baa62b05578d3d808bd2ff1b40458d99bbfa77bdc4b7ac3a2e84b594b66","abstract_canon_sha256":"6b9d77f34aac675a84c098a9cfe57275798e01ce7d7947dd5e312af90385cddb"},"schema_version":"1.0"},"canonical_sha256":"32c395fa603e291dd3ecbd90053fc8751955501391e27efd52ff9cc77a2ff8ba","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T11:13:36.885553Z","signature_b64":"4aoybAg041otRt8NGsMFxkh5hWMCPauKt+E1SxEbMku2Mg+1JzSWg7kQl/FWisomY79Ttf5WHEh2X+fxxDInBQ==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"32c395fa603e291dd3ecbd90053fc8751955501391e27efd52ff9cc77a2ff8ba","last_reissued_at":"2026-07-05T11:13:36.885137Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T11:13:36.885137Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"2506.00556","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-07-05T11:13:36Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"EIo/6JhmluA1ZJ0jxdP/xlfPq/QT8WmVB8COa0wF2Bc18iNdOc536wmnsQ4W0YCcMGDUvll/d1ZY4H7IeqAvBg==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-09T02:37:57.385683Z"},"content_sha256":"fa1956908413d200a836184a48c160b8b6a08bb545cb9160ff56987e061fbf21","schema_version":"1.0","event_id":"sha256:fa1956908413d200a836184a48c160b8b6a08bb545cb9160ff56987e061fbf21"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2025:GLBZL6TAHYUR3U7MXWIAKP6IOU","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Estimands for Randomized Discontinuation Designs in Oncology","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":[],"primary_cat":"stat.ME","authors_text":"Ayon Mukherjee, Ngoc-Thuy Ha, Oleksandr Sverdlov, Yu Deng","submitted_at":"2025-05-31T13:24:05Z","abstract_excerpt":"Randomized discontinuation design (RDD) is an enrichment strategy commonly used to address limitations of traditional placebo-controlled trials, particularly the ethical concern of prolonged placebo exposure. RDD consists of two phases: an initial open-label phase in which all eligible patients receive the investigational medicinal product (IMP), followed by a double-blind phase in which responders are randomized to continue with the IMP or switch to placebo. This design tests whether the IMP provides benefit beyond the placebo effect. The estimand framework introduced in ICH E9(R1) strengthen"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2506.00556","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2506.00556/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-07-05T11:13:36Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"Z/fh6+6ctXWFREdGRtIx1IB89bbyARoe8t5CJbJicrnoDnyVpjKDPbBvSX8OZUWBv/bGrbWW8CR1KgVuMlyCAQ==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-09T02:37:57.386252Z"},"content_sha256":"1de265d19baeac6530f3cd0bd5dab34fd7795dcd72b1e31fb4ad1c8215c0eca8","schema_version":"1.0","event_id":"sha256:1de265d19baeac6530f3cd0bd5dab34fd7795dcd72b1e31fb4ad1c8215c0eca8"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/GLBZL6TAHYUR3U7MXWIAKP6IOU/bundle.json","state_url":"https://pith.science/pith/GLBZL6TAHYUR3U7MXWIAKP6IOU/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/GLBZL6TAHYUR3U7MXWIAKP6IOU/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-08-09T02:37:57Z","links":{"resolver":"https://pith.science/pith/GLBZL6TAHYUR3U7MXWIAKP6IOU","bundle":"https://pith.science/pith/GLBZL6TAHYUR3U7MXWIAKP6IOU/bundle.json","state":"https://pith.science/pith/GLBZL6TAHYUR3U7MXWIAKP6IOU/state.json","well_known_bundle":"https://pith.science/.well-known/pith/GLBZL6TAHYUR3U7MXWIAKP6IOU/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2025:GLBZL6TAHYUR3U7MXWIAKP6IOU","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"6b9d77f34aac675a84c098a9cfe57275798e01ce7d7947dd5e312af90385cddb","cross_cats_sorted":[],"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"stat.ME","submitted_at":"2025-05-31T13:24:05Z","title_canon_sha256":"cba29baa62b05578d3d808bd2ff1b40458d99bbfa77bdc4b7ac3a2e84b594b66"},"schema_version":"1.0","source":{"id":"2506.00556","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2506.00556","created_at":"2026-07-05T11:13:36Z"},{"alias_kind":"arxiv_version","alias_value":"2506.00556v1","created_at":"2026-07-05T11:13:36Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2506.00556","created_at":"2026-07-05T11:13:36Z"},{"alias_kind":"pith_short_12","alias_value":"GLBZL6TAHYUR","created_at":"2026-07-05T11:13:36Z"},{"alias_kind":"pith_short_16","alias_value":"GLBZL6TAHYUR3U7M","created_at":"2026-07-05T11:13:36Z"},{"alias_kind":"pith_short_8","alias_value":"GLBZL6TA","created_at":"2026-07-05T11:13:36Z"}],"graph_snapshots":[{"event_id":"sha256:1de265d19baeac6530f3cd0bd5dab34fd7795dcd72b1e31fb4ad1c8215c0eca8","target":"graph","created_at":"2026-07-05T11:13:36Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"integrity":{"available":true,"clean":true,"detectors_run":[],"endpoint":"/pith/2506.00556/integrity.json","findings":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938","summary":{"advisory":0,"by_detector":{},"critical":0,"informational":0}},"paper":{"abstract_excerpt":"Randomized discontinuation design (RDD) is an enrichment strategy commonly used to address limitations of traditional placebo-controlled trials, particularly the ethical concern of prolonged placebo exposure. RDD consists of two phases: an initial open-label phase in which all eligible patients receive the investigational medicinal product (IMP), followed by a double-blind phase in which responders are randomized to continue with the IMP or switch to placebo. This design tests whether the IMP provides benefit beyond the placebo effect. The estimand framework introduced in ICH E9(R1) strengthen","authors_text":"Ayon Mukherjee, Ngoc-Thuy Ha, Oleksandr Sverdlov, Yu Deng","cross_cats":[],"headline":"","license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"stat.ME","submitted_at":"2025-05-31T13:24:05Z","title":"Estimands for Randomized Discontinuation Designs in Oncology"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2506.00556","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:fa1956908413d200a836184a48c160b8b6a08bb545cb9160ff56987e061fbf21","target":"record","created_at":"2026-07-05T11:13:36Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"6b9d77f34aac675a84c098a9cfe57275798e01ce7d7947dd5e312af90385cddb","cross_cats_sorted":[],"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"stat.ME","submitted_at":"2025-05-31T13:24:05Z","title_canon_sha256":"cba29baa62b05578d3d808bd2ff1b40458d99bbfa77bdc4b7ac3a2e84b594b66"},"schema_version":"1.0","source":{"id":"2506.00556","kind":"arxiv","version":1}},"canonical_sha256":"32c395fa603e291dd3ecbd90053fc8751955501391e27efd52ff9cc77a2ff8ba","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"32c395fa603e291dd3ecbd90053fc8751955501391e27efd52ff9cc77a2ff8ba","first_computed_at":"2026-07-05T11:13:36.885137Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-07-05T11:13:36.885137Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"4aoybAg041otRt8NGsMFxkh5hWMCPauKt+E1SxEbMku2Mg+1JzSWg7kQl/FWisomY79Ttf5WHEh2X+fxxDInBQ==","signature_status":"signed_v1","signed_at":"2026-07-05T11:13:36.885553Z","signed_message":"canonical_sha256_bytes"},"source_id":"2506.00556","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:fa1956908413d200a836184a48c160b8b6a08bb545cb9160ff56987e061fbf21","sha256:1de265d19baeac6530f3cd0bd5dab34fd7795dcd72b1e31fb4ad1c8215c0eca8"],"state_sha256":"ef0e405cfac8089b42c095e2fbb0f9517df349004fd2b2576d1ba2345cc916c1"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"rZStnDc9i8li/GJmlN+K4wemScgS3rzGVWwx02khNqM3Q8fmcUPrl6+p1Ss+oIntl2bTdNDveOP3ao0MnO3qAA==","signed_message":"bundle_sha256_bytes","signed_at":"2026-08-09T02:37:57.390194Z","bundle_sha256":"0c31b901b0c3b52a0043ad9affca65483a50d495666ff159d350e3972430e498"}}